Clinical Trial Update: Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy trial of JTT-130 in obese patients with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• JTT-130

Snippet

Sponsor: Akros Pharma Inc. | Conditions: Type II Diabetes Mellitus | Phase 2 | Status: COMPLETED